Highlights2016_EDR_FinalTranslation_REV2

First Page		Document Content
Date: 2016-05-31 06:21:55 Drug culture Euphoriants Entheogens Psychedelics dissociatives and deliriants Drug control law MDMA Stimulant European Monitoring Centre for Drugs and Drug Addiction Designer drug Drug policy Harm reduction Poly drug use		Highlights2016_EDR_FinalTranslation_REV2 Add to Reading List Source URL: www.dbdd.de Download Document from Source Website File Size: 230,32 KB Share Document on Facebook

	FLUBROMAZEPAM Stephanie Hopkins, California Department of Justice, 4949 Broadway, Room F-249, Sacramento CA, Manufacturer: A “designer” drug. First described in 1962 by Sternbach ( DocID: 1u7eJ - View Document
	FLUBROMAZEPAM Stephanie Hopkins, California Department of Justice, 4949 Broadway, Room F-249, Sacramento CA, Manufacturer: A “designer” drug. First described in 1962 by Sternbach ( DocID: 1u2MR - View Document
	Ekctmchimica Acta,Vol.39.No. 4.ppCopyri&tt Q 1994 Elsevier Scicna Ltd. Printed inGreatBritainAU rights mewed DocID: 1sNHy - View Document
	LETTER 555 A Simple Protocol for Direct Reductive Amination of Aldehydes and Ketones Using Potassium Formate and Catalytic Palladium Acetate DocID: 1stBf - View Document
	TETRAHEDRON Pergamon Tetrahedron±5674 A modi®ed palladium catalysed reductive amination procedure DocID: 1rDwT - View Document